WO2003008037A2 - Automatic implantable medical lead recognition and configuration - Google Patents
Automatic implantable medical lead recognition and configuration Download PDFInfo
- Publication number
- WO2003008037A2 WO2003008037A2 PCT/US2002/023294 US0223294W WO03008037A2 WO 2003008037 A2 WO2003008037 A2 WO 2003008037A2 US 0223294 W US0223294 W US 0223294W WO 03008037 A2 WO03008037 A2 WO 03008037A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- imd
- circuit
- communication circuit
- data signals
- transponder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/025—Digital circuitry features of electrotherapy devices, e.g. memory, clocks, processors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37252—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
- A61N1/37254—Pacemaker or defibrillator security, e.g. to prevent or inhibit programming alterations by hackers or unauthorised individuals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
- A61B2560/0219—Operational features of power management of power generation or supply of externally powered implanted units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
- A61N1/37223—Circuits for electromagnetic coupling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
- A61N1/3752—Details of casing-lead connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N2001/0585—Coronary sinus electrodes
Definitions
- the present invention relates generally to implantable medical devices; and, more particularly, to a method and apparatus to automatically identify multiple leads and their proper connection to an implantable medical device such as a pacemaker or cardioverter/def ⁇ brillator.
- An implantable intravascular lead assembly is often implanted within a patient's body to provide electrical stimulation to the heart.
- Such lead assemblies may include one or more electrical conductors that are adapted to be suitably connected to a source of electrical energy, which may be a pacemaker or cardioverter/defibrillator.
- the electrical - conductor includes an electrode tip that engages the endocardial or epicardial tissue of the heart to provide stimulation and sensing capabilities.
- the lead assembly may be intravenously inserted through a body vessel, such as a vein, into one or more cardiac chambers, or alternatively, attached to the epicardial surface of the heart.
- the conductor is sealed from body fluids by a biocompatible and bio-stable insulating material.
- the electrode tip is firmly lodged in, and permanently secured to, the endothelial lining or epicardial surface of the heart.
- These lead assemblies are referred to as an endocardial or epicardial lead, respectively.
- Some examples of conventional endocardial and epicardial leads may be found in U.S. Patent No. 3,348,548 to Chardack, U.S. Patent No. 3,754,555 to Schmitt, U.S. Patent No. 3,814,104 to Irnich et al., U.S. Patent No. 3,844,292 to Bolduc, U.S. Patent No. 3,974,834 to Kane, U.S. Patent
- multiple leads are required to deliver electrical stimulation to various locations within the heart.
- multiple leads that are positioned within one or more small vessels of the body, it has become even more important to minimize lead and lead connector size.
- leads become smaller, it becomes increasingly difficult to mark leads with the appropriate identification, including manufacturer identification and/or lead model and serial numbers. This may make it more difficult for a physician to determine which lead is to be inserted into a given port of an implantable medical device (IMD) during an implant procedure.
- IMD implantable medical device
- the described medical electrical pulse generator includes a switchable connector assembly.
- the connector assembly is provided with connector bores that are each adapted to receive a medical electrical lead. Electrical connectors located within the bores are arranged such that interconnection of the pulse generator circuitry and the configuration of the electrodes on the leads and/or housing of the device can be altered by means of connector pins.
- U.S. Patent No. 6,085,118 to Hirschberg describes an implantable cardiac stimulator with at least two terminals. Each terminal is cormectable to an implantable electrode for delivering stimulation pulses to a heart, and/or for sensing cardiac activity signals.
- the stimulator also has a switch and a control unit which operates the switch, so that one or both terminals are cormectable to the pulse generator.
- the control unit identifies a position status for at least one of the electrodes in response to a signal received at the time of implantation. Although the control unit may use a signal from an electrode to configure the switch, premature sensed events, artifacts and/or EMI may cause the control unit to incorrectly configure the system.
- U.S. Patent No. 5,300,120 to Knapp involves a passive transponder that may be encoded with a binary value that may be up to sixty-four bits long. This value may be read with a hand-held electromagnetic device that is located outside the body and in proximity to the transponder.
- the encoded information may include patient demographics, implant data, and manufacturer information.
- the disclosed telemetry system includes a remote monitoring station, a repeater worn externally by a patient, and a quasipassive transponder attached to a device implanted in the patient.
- the remote monitoring station communicates to the repeater to initiate an interrogation routine between the repeater and the transponder to extract patient condition information from the implanted device.
- the repeater receives the condition information, it relays it to the remote monitoring station.
- the disclosed system does not automatically identify leads, calibrate lead-based sensors, or automatically configure leads and/or sensors to an IMD.
- U.S. Patent No. 5,833,603 to Kovacs describes another system for sensing one or more physiological signals within a living body to measure optical, mechanical, chemical, and/or electrochemical properties.
- the system includes a transponder for wirelessly transmitting data corresponding to the sensed parameter values to a remote reader.
- Disclosed embodiments utilize temperature sensors, strain sensors, pressure sensors, magnetic sensors, acceleration sensors, ionizing radiation sensors, acoustic wave sensors, chemical sensors, and photosensors.
- the disclosed system does not include means to automatically identify or configure leads, or to calibrate the lead-based sensors. Another mechanism for identifying information related to the configuration of an
- the disclosed system provides a characterization tag for attachment to the IMD.
- the tag circuitry is selectively loaded to store data describing the IMD, and may be read by a probe located outside the body.
- the system does not store lead identification or configuration information.
- the disclosed device includes a sensor for use in transmitting a parameter such as temperature from within a living body to a device that is located outside the body.
- the IMD includes a programmable memory to store user ID data.
- Another object is to provide a system and method for automatically identifying leads and for enabling the proper connection of the identified leads to an IMD.
- Another object is to provide an IMD that automatically configures connections between one or more leads and respective IMD ports.
- An additional object is to provide a connector block for electrically and mechanically coupling multiple leads or sensors to an electrical source of energy, such as a pacemaker, defibrillator or neuro stimulator.
- Yet another object is to provide a system for use with an IMD that allows an additional component of the IMD to be automatically identified for purposes of system configuration. It is a further object to provide a system for use with an IMD that stores patient data that may be transferred to a central location for use in performing diagnosis and therapy.
- the current system and method addresses these and other objectives by providing a system for use with an active IMD (hereinafter, "IMD") such as a pacing device, or another external device.
- IMD active IMD
- the system is capable of automatically identifying one or more additional implantable medical devices such as leads that may be associated with the IMD.
- the invention includes a first communication circuit that is attached to, or integrated within, a lead.
- the communication circuit stores data such as model and serial numbers, technical information, and calibration data.
- information stored by the first communication circuit may be transferred to a second communications circuit that is external to the lead.
- the second communications circuit may reside within the IMD, an external programmer, a personal data management (PDM) unit, or within any other unit such as a Personal Digital Assistant (PDA) that is located within a predetermined range of the first communication circuit.
- PDM personal data management
- PDA Personal Digital Assistant
- This transferred data can be used both to indicate the presence of the lead, and to identify lead type. Such information can be used, for example, to automatically configure the connector block of the IMD to properly couple to the lead. The data can further be used to automatically adjust amplifier gains or other circuitry associated with the lead. The data may be entered into a patient record on an external programmer, or may be transferred to a central storage location for use by health care providers when performing diagnosis and therapy associated with the IMD.
- the data provided by the first communications circuit includes identification and calibration information concerning additional components of the system.
- physiologic sensors carried on the leads may be identified so that the IMD can enable and calibrate internal circuitry to receive the physiologic signals. This allows certain functions within the IMD to automatically be enabled only when a component is present in the system so that power can otherwise be conserved.
- Any other components of an IMD may be identified and calibrated by using a communication circuit according to the current invention. This may include implantable devices such as pluggable antennas, electrodes that can be selectively coupled to the IMD case, and any other types of components that may be selectively added to the system.
- the first communication circuit may be a passively-powered RF transponder.
- the transponder receives power from an external source. Ultrasonic, optical, and electromagnetic power may be used to power the first communication circuit.
- the first communication circuit may receive power from its host unit, such as via the conductors of a lead.
- the first communication circuit may include a receiver as well as a transmitter to receive data signals from an external source. This allows the first communication circuit to be programmed with identification, calibration, and other data at the time of component manufacture.
- FIG. 1 is a schematic view of an implantable medical device (IMD) implanted within a body.
- IMD implantable medical device
- Figure 2 is a side cutaway view of an exemplary in-line connector assembly at line 2-2 of Figure 1
- Figure 3 is a side perspective view of one embodiment of passive transponder of Figure 2.
- Figure 4 is a side perspective view illustrating a sealed transponder coupled to a lead.
- FIG. 5 is a system block diagram of one embodiment of an IMD that may utilize the current invention.
- Figure 6 is a circuit block diagram illustrating in more detail exemplary components of the transponder and transmitter/receiver circuit of Figure 5.
- Figure 7 is a system block diagram illustrating additional embodiments of the present invention.
- Figure 8 is a circuit diagram illustrating a transponder coupled to the therapy output energy source of an IMD.
- Figure 1 is a schematic view of an implantable medical device (IMD) 12 implanted within a body. Leads 14 and 15 are shown coupled to the connector assembly 20 of IMD 12 using one or more feedthroughs. IMD 12, which may be implanted near a human heart
- implantable medical device 12 may be an implantable cardiac pacemaker such as that described in U.S. Patent No. 5,158,078 to Bennett et al., U.S. Patent No. 5,312,453 to Shelton et al., or U.S. Patent No. 5,144,949 to Olson et al.
- IMD 12 may be a pacemaker-cardioverter-defibrillator (PCD) such as those described in U.S. Patent No. 5,545,186 to Olson et al., U.S. Patent No. 5,354,316 to Keimel, U.S. Patent No. 5,314,430 to Bardy, U.S. Patent No. 5,131,388 to Pless, or U.S. Patent No. 4,821,723 to Baker, et al.
- IMD 12 may be an implantable neurostimulator or muscle stimulator such as those disclosed in U.S. Patent
- FIG. 2 is a side cutaway view of an exemplary in-line connector assembly 20 at line 2-2 of Figure 1. The connector assembly is shown coupled to a proximal end of lead 14.
- Connector assembly 20 employs a "setscrewless" lead retainer, and a stepped lumen 202 that receives a connector pin mounted to the proximal end of lead 14.
- the connector pin includes two conductive connector surfaces 208 and 210, and two insulative areas 212 and 214. Insulative areas 212 and 214 are each provided with a plurality of sealing rings
- Conductive area 208 may take the form of a metallic, cylindrical pin.
- Conductive area 210 is illustrated as a metal cylinder.
- Connector assembly 20 is shown mounted to the outer enclosure 222 of IMD 12. Connection between the implantable pacemaker and the lead 14 is made by means of spring members 224 and 226, which are mounted in conductive ferrules 228 and 230, respectively.
- Females 228 and 230 are metal cylinders having central bores and associated internal circumferential grooves that retain the spring members 224 and 226. When inserted, spring members 224 and 226 provide for electrical coupling. Ferrules 228 and 230 are coupled to feedthrough wires 232 and 234 by means of wires 236 and 238, respectively.
- the proximal end of lead 14 is shown provided with a cylindrical plastic member 240 that includes a circumferential groove 242 that mates with a deflectable beam lead retainer 244 provided at the distal end of the connector assembly 20.
- the lead retainer 244 is integrally molded to connector module 20, although the retainer may also be fabricated separately.
- the proximal end of lead 14 further includes a first and second communication circuit, which in this embodiment are a passive transponder 262 adapted to communicate with transmitter/receiver 260, respectively.
- This communication may be facilitated by RF transmissions as substantially described in U.S. Patent Nos. 4,730,188, 5,041,826, and 5,166,676 to Milheiser, U.S. Patent No. 5,025,550 to Zirbes, or U.S. Patent Nos. 5,223,851 and 5,281 ,855 to Hadden, incorporated herein by reference in their entireties.
- passive transponders include an energy coupler for wirelessly coupling electromagnetic, ultrasonic, or optical energy, for example, that is provided by a remote energy source.
- the energy source is provided by transmitter/receiver 260.
- Energy may also be provided by another circuit in the IMD.
- Passive transponder 262 further includes a communication circuit powered by the energy received from the remote energy source, and that is adapted to transfer a signal indicative of identification data stored within the transponder. This will be discussed further below.
- FIG. 3 is a side perspective view of one embodiment of passive transponder 262 of Figure 2.
- the transponder includes a wire coil antenna 106 encircling bobbin 108. This antenna may be tuned to the frequency of the carrier signal using an RLC tuned resonant circuit including capacitor 105 to allow for more efficient signal transmission.
- the center of bobbin 108 includes a lumen 109 to receive a lead.
- FIG. 3 further illustrates a surface acoustic wave (SAW) filter 104 to filter signals transmitted by the RF receiver/transmitter circuitry in a manner described further below.
- SAW surface acoustic wave
- FIG 4 is a side perspective view illustrating a sealed transponder 262 coupled to lead 14.
- the sealed transponder 262 may be inserted under a connector sleeve (not shown in Figure 4) and backfilled with medical adhesive.
- the transponder of Figure 3 may be coupled to the lead in many other ways.
- the transponder may be fully integrated within the lead body instead of being provided as a separate component.
- FIG. 5 is a system block diagram of one embodiment of an IMD that may utilize the current invention.
- IMD 300 is provided with an input/output circuit 320 to sense physiological signals and/or to provide electrical stimulation to a patient. If IMD 300 is a pacemaker, input/output circuit 320 may provide all of the basic timing, stimulation and sensing functions of a DDD or DDDR of a commercially-available pacing device.
- Input/output circuit 320 provides the control functions of the IMD.
- digital controller/timer 330 which receives a clock signal from crystal oscillator circuit 338, generates the appropriate timing and control sequences for the rest of the IMD.
- Battery 318 provides power for all the components of the IMD, and power-on-reset circuit 336 defines an initial operating condition and also resets the operative state of the device in response to detection of a low battery condition.
- Reference mode circuit 326 generates stable voltage and currents references for the analog circuits within input/output circuit 320.
- Figure 5 also illustrates leads 14 and 15 coupled to IMD 300. Additional leads ⁇ catheters such as exemplary lead 26 may further be implanted within the body for sensing signals and/or for providing electrical stimulation or drug therapy in a manner to be discussed below. One or more of these leads may carry one or more electrodes.
- Lead 14, which may be an atrial bipolar pacing lead, is shown carrying two electrodes 19 and 21 positioned in the right atrium of heart 16.
- Electrodes 19 and 21 may be used both to sense and pace the atrium in a manner well known in the art.
- lead 15 represents a ventricular bipolar lead that may carry two electrodes 23 and 25 implanted in the right ventricle of the heart 16. As discussed above in conjunction with atrial lead 14, electrodes 23 and 25 may be used to sense and pace the ventricle in a manner well known in the art.
- sensors may be provided to measure oxygen saturation, change in pressure dP/dT, temperature, minute ventilation or respiration rate.
- Exemplary sensor systems are described in U.S. Patent No. 5,154,170 to Bennett et al., U.S. Patent No. 5,144,524 to Reuter, U.S. Patent No. 5,271,395 to Wahlstrand, and U.S. Patent No.4,485,813 to Anderson.
- Analog signals sensed by any of the sensors and/or electrodes may be provided to a programmable electronic switch such as selection circuit 361 to be described further below.
- the selected signals are provided to sense amplifiers 360.
- the gain of sense amplifiers 360 may be controlled via controller/timer circuit 330 via gain/energy control 348.
- the amplified analog signals are received by controller/timer circuit, and provided to analog-to-digital converter (ADC) and multiplexor circuit 328.
- ADC analog-to-digital converter
- the ADC digitizes the analog signals so that the signals may be stored and/or transferred to an external device such as a programmer.
- RF transmitter/ receiver circuit 332 demodulates received downlink telemetry communications and transmits uplink telemetry data.
- An exemplary circuit for demodulating and decoding downlink telemetry may correspond to that disclosed in U.S. Patent No. 4,556,063, while uplink telemetry functions may be provided according to U.S. Patent Nos. 5,127,404 and 4,374,382.
- Uplink telemetry capabilities will typically include the ability to transmit stored digital information as well as physiological signals sensed in real-time as described in the '404 patent. It may also be capable of transmitting marker signals indicating the occurrence of sensed and paced depolarizations in the atrium and ventricle, as disclosed in the cited '382 patent.
- IMD 300 further includes a microcomputer circuit 302.
- This circuit controls the operational functions of digital controller/timer circuit 330 via data and control bus 306 by specifying, for example, which timing intervals are employed for performing pacing and sensing functions.
- Microcomputer 302 may include a microprocessor 304 and associated system clock 308 and on-board processor RAM and ROM 310 and 312, respectively.
- microcomputer circuit 302 may include an additional storage unit such as RAM/ROM circuit 314 to provide additional memory capacity.
- Microprocessor 304 may be interrupt driven, operating in a reduced power consumption mode normally, and awakened in response to defined interrupt events, which may include sensed physiological signals.
- controller/timer 330 further interfaces directly or indirectly with a battery 318, an activity sensor 30, a telemetry antenna 334, and various feedthroughs (not shown in Figure 5) to the lead connector elements included in connector assembly 20 discussed above.
- a piezoelectric crystal activity sensor 30 may be provided to generate electrical pressure wave signals in response to sensed physical activity. The generated signal is processed by activity circuit 322, which, in turn, provides activity signal 324 to digital controller/timer circuit 330.
- Activity circuit 322 and associated activity sensor 30 may correspond to the circuit and sensor disclosed in U.S. Patent No. 5,052,388 to Sivula et al., incorporated herein by reference in its entirety.
- IMD 300 also includes an output amplifier circuit 340 to provide electrical stimulation to heart 16 via one or more of electrodes 23 and 25 on lead 18 V, as well as one or more of electrodes 19 and 21 located on lead 18 A.
- digital controller/timer circuit 330 In order to trigger generation of a ventricular pacing or V-PACE pulse, digital controller/timer circuit 330 generates a trigger signal on V-TRIG line 342. Similarly, in order to trigger an atrial pacing or A-PACE pulse, digital controller/timer circuit 330 generates a trigger pulse on A-TRIG line 344.
- the A-PACE and V-PACE pulse energies may be controlled in pulse width and/or amplitude by gain/energy control 348 which receives a pace energy command signal from digital timer/controller circuit 330.
- the timing of pacing signals may be controlled based on programmable rate-response features that take into consideration one or more measured physiological parameters as known in the art.
- Digital controller/timer circuit 330 defines the pacing or escape intervals used to pace the atrium and ventricle using any of the sensing and timing mechanisms known in the art.
- the signals generated by output amplifier circuit may be provided to a programmable switch such as selection circuit 341, which is programmed by controller/timer 330 in a manner to be discussed below.
- controller/timer circuit is further shown coupled to transmitter/receiver 380, which, in turn, is coupled via connection 386 to RF antenna 260.
- This antenna transmits energy to passive transponder 262 carried on lead 14.
- the energy which may be optical, electromagnetic, or ultrasonic, for example, is used to power circuitry within passive transponder 262 such that the transponder initiates a data transfer operation to the transmitter/receiver 380.
- This transferred data may include lead and sensor identification information stored by the transponder and used by IMD 12 to configure the system in a manner to be discussed further below.
- transmitter/receiver 380 decodes data received from the transponder 262, and provides this data to digital controller/timer circuit 330 for subsequent storage in RAM/ROM unit 314. The data may also be transmitted to an external programmer 420 (not shown in figure 5) via antenna 334. Digital controller/timer circuit 330 may initiate an interrogation of the transponder following lead implant detection via antenna 260. Lead implant detection may be performed as described in U.S. Patent No. 5,534,018 and 6,016,447 to Wahlstrand and Juran, respectively, incorporated herein by reference in their entireties.
- FIG. 5 illustrates transmitter/receiver circuit 380 as being a separate circuit as compared to transmitter/receiver 332, the two circuits may be included as a single circuit providing both the ability to transfer and receive data to/from an outside device, and to further receive and/or transmit data from one or more transponders such as transponder 262.
- Figure 6 is a circuit block diagram illustrating in more detail exemplary components of transponder 262 and transmitter/receiver circuit 380 of Figure 5.
- Transmitter/Receiver 380 includes an energy source 390, which may be an inductive circuit, or a photoelectric or piezoelectric transducer to generate electromagnetic, ultrasonic, or optical energy, respectively, as represented by line 391.
- Transponder includes a control circuit 393, which is coupled to a non-volatile storage device 394.
- the non-volatile storage device may be a switch device, or any other type of non-volatile storage device known in the art, including a read-only memory (ROM).
- ROM read-only memory
- One or more data values indicative of device type, device technical information, and/or device configuration information may be stored in storage device 394 and read by control circuit 393.
- the control circuit 393 provides this information to transmitter/receiver 395, which transmits the data via an RF or other type of communication to transmitter/receiver 396. This transmission is indicated by line 397.
- Transmitter/Receiver 380 further includes a transmitter/receiver 396 that may provide an unmodulated carrier signal to transmitter/receiver 395.
- Transmitter/receiver 395 has a tuned resonant circuit as discussed above for resonating at the frequency of the carrier signal to re-transmit a signal at the carrier frequency.
- the transmitter/receiver 395 also includes means for superimposing an information signal on the re-transmitted signal by modulating the carrier or harmonies of the carrier to reflect the information stored by storage device 394. It may be noted that in an alternative embodiment, the signal provided by the transmitter/receiver 396 is used both as the energy source and the carrier signal such that energy source 390 is not needed.
- transmitter/receiver 395 may be programmed with information from an external transmitter/receiver circuit at the time of manufacture.
- This information may include model and serial numbers, lot numbers, expiration dates, electrical characteristics, labeling changes, cautions, product performance results, recall information, and shipping information such a freight IDs and the like.
- the transponder could further be programmed to store intended therapy information, indications for use, and calibration parameters. All, or portions of, associated technical manuals may be downloaded to the transponder as permitted by the capacity of the storage device. If transponder is capable of receiving data from an external device in the manner discussed above, data stored within the IMD may be loaded into storage device 394. For example, storage device 394 may store the therapy settings and/or any programmable parameters used to calibrate the IMD for a specific patient.
- transponder 362 These stored settings and parameters could then be automatically uploaded from transponder 362 following a replacement procedure during which the patient receives a new IMD. This saves time, since manual intervention is not required to configure the newly-implanted device.
- Other information may likewise be downloaded to transponder 362, including general patient information and health history, and information associated with drug therapies that may or may not be coordinated with the therapy provided by the IMD.
- a physician may store information such as threshold values, lead or other impedance values, and/or additional operational and diagnostic information that are determined either at the time of implant, or during subsequent patient visits.
- Information from one or more transponders may be obtained by the input/output circuit 320 in the manner discussed above.
- This information may be stored in memory of the IMD such as memory within microcomputer circuit 302.
- the data may also be transferred to an external device for storage with patient record data.
- This information may be analyzed by microcomputer circuit 302 or an external processor to automatically configure the IMD.
- this data can be used by the processor to adjust gain/energy control circuit 348 in a manner that controls the gains of output amplifier circuit 340 and sense amplifiers 360.
- the adjustments may be based on the type of leads and sensors that are detected in the system. According to one aspect of the system, in the event a particular lead or sensor is not present, unused functions within the IMD may be placed in a low-power mode to conserve battery power.
- Physiological sensors such as pressure, temperature, oxygen saturation, or any of the other sensors types known in the art to measure physiological parameters often have operating parameters that vary widely. This is a result of variable conditions that occur during the manufacturing process, as well as differences associated with materials used during production. Therefore, different sensors of the same type may have significantly different scale factors, offsets, and gains.
- One way to compensate for such variability involves performing a test at the time of implant. A physician may test sensor operation and calibrate the sensor to account for the variable factors. A system and method for performing this type of calibration is described in U.S. Patent No. 5,919,221.
- This type of calibration procedure may be time-consuming and error prone, however.
- sensors may be tested at the time of manufacture to determine specific operating parameters. These parameters may then be stored in transponder storage device 394, which may be carried on the sensor lead or the sensor itself. These parameters may be transferred to an IMD in the manner discussed above for use in automatically adjusting sensor gains to account for the sensor differences, and may be further used to adjust and calibrate the IMD functions associated with the sensors. For example, sensor output could be calibrated if an active sensor is being utilized. Such parameters may also be used by a data processing system such as microcomputer 302 to adjust digital values derived from the measured sensor signals.
- Information gained from the transponder may also be used by controller/timer 330 to control selection circuits 361 and 341.
- the signals provided to sense amplifiers 360 may be selected by selection circuit 361 based on the leads and/or sensors being used by a particular system.
- the signals that are driven by output amplifier circuit 340 may be selected by selection circuit 341 based on whether a lead or a particular electrode is available within the system, and is being used to provide therapy for a given patient.
- the selection circuits thereby provide "plug-and-play" capabilities for the IMD connector block based on the devices that are sensed within the system.
- Information provided by the transponder may further be used to select the configuration of switchable circuits such as those described in U.S. Patent No.
- the configuration of the switchable circuits controls one or more operating parameters of the device, such as input amplifier parameters and filter settings and sensitivity. This configuration can be modified based on the type of components available within the system as indicated by data stored in one or more of transponder circuits 362.
- the uses of the configuration and calibration data discussed above are exemplary only, and it will be understood that such data may be used in many other ways to program or automatically calibrate electronic circuitry associated with an IMD or an external device used with the IMD.
- Figure 7 is a system block diagram of additional embodiments of the present invention.
- IMD 410 a bi-directional wireless communications system between programmer 420, personal data management (PDM) unit 420' and a number of implantable medical devices (IMDS) represented by IMD 410, IMD 410' and IMD 410" is shown.
- the IMDs are implanted in patient 10 beneath the skin or muscle.
- the IMDs are electrically coupled to electrodes 418, 430, and 436 respectively in a manner known in the art.
- IMD 410 may include a microprocessor for timing, sensing and pacing functions consistent with preset programmed functions as discussed above.
- IMDs 410' and 410" may be microprocessor-based to provide timing and sensing functions to execute the clinical functions for which they are employed.
- IMD 410' could provide neural stimulation to the brain via electrode 430 and IMD 410", and/or may function as a drug delivery system that is controlled by electrode 436.
- the various functions of the IMDs may be coordinated using wireless telemetry.
- Wireless links 442, 444 and 446 jointly and severally couple IMDs 410, 410' and 410" such that programmer 420 may transmit commands or data to any or all the of IMDs via one of telemetry antennas 428, 432 and 438.
- This configuration provides a highly flexible and economical wireless communications system between the IMDS.
- the structure provides a redundant communications system, which enables access to any one of a multiplicity of IMDs in the event of a malfunction of one or two of antennas 428, 432 and 438. Programming commands or data are transmitted from programmer 420 to IMDs
- Telemetry antenna 424 may be an RF head or equivalent. Antenna 424 may be located on programmer 420 externally on the case or housing. Telemetry antenna 424 is generally telescoping and may be adjustable on the case of programmer 420. Both programmer 420 and PDM unit 420' may be placed a few feet away from patient 10 and would still be within range to wirelessly communicate with telemetry antennas 428, 432 and 438. In one embodiment, a remote web-based expert data center 462 may be accomplished through programmer 420 or PDM unit 420'.
- programmer 420 and PDM unit 420' function as an interface between IMDs 410, 410' and 410" and data center 462.
- One of the many distinguishing elements of the present invention includes the use of various scalable, reliable and high-speed wireless communication systems to bi-directionally transmit high fidelity digital/analog data between programmer 420 and data center 462.
- the communications link between programmer 420 or PDM unit 420' and data center 462 could be modem 460, which is connected both to programmer 420 and to data center 462.
- Alternative data transmission systems include, without limitations, stationary microwave and/or RF antennas 448 being wirelessly connected to programmer 420 via tunable frequency wave 450, and with data center 462 via wireless link 465.
- PDM unit 420', mobile vehicle 452, and satellite 456 are in communications with data center 462 via similar wireless links.
- mobile system 452 and satellite 456 are in wireless communications with programmer 420 or PDM unit 420' via tunable frequency waves 454 and 458, respectively.
- a telnet system may be used to wirelessly access data center 462.
- Telnet emulates a client/server model and requires that the client run dedicated software to access data center 462.
- the telnet scheme may employ various operating systems including UNIX, Macintosh, and all versions of Windows.
- an operator at programmer 420 or data center 462 may initiate remote contact with any of the implanted devices via link antennas 428, 432 and 438 to enable data reception and transmission.
- an operator or a clinician at data center 462 may downlink to programmer 420 to perform a routine evaluation of programmer 420. If a downlink is required from programmer 420 to IMD 410 for example, the downlink is affected using telemetry antenna 422. In the alternate, if an uplink is initiated from patient 10 to programmer 420, the uplink is executed via wireless link 426.
- Each antenna from the IMDs can be used to uplink all or one of the IMDs to programmer 420.
- IMD 410 which relates to neural implant 430, can be implemented to up-link, via wireless antenna 434 or wireless antenna 434', any one, two or more IMDs to programmer 420.
- Bluetooth or equivalent chips adopted to function within a body and which result in low current drain, are included in the IMD to provide wireless and seamless connections 442, 444 and 446 between IMDs 410, 410' and 410".
- the communication scheme is designed to be broadband compatible and capable of simultaneously supporting multiple information sets and architecture, transmitting at relatively high speed, to provide data, sound and video services on demand.
- the various communication paths as shown in Figure 6 allow lead identification and sensor configuration data to be uploaded to either programmer 420, or to data center 462.
- a transmitter/receiver such as transmitter/receiver 380 ( Figure 5) may be resident in programmer 420.
- This transmitter/receiver may interrogate transponders provided on one or more of the leads to determine lead types, serial numbers, and any available sensor calibration values in a manner similar to that described above.
- the transfer of information from the transponders may be performed using data encryption technology as described in the co-pending application entitled “Method and Apparatus to Secure Data Transfer from Medical Device Systems", serial no. 09/431,881 filed November 2, 1999 by Nichols and incorporated herein by reference.
- Information that is gained during the interrogation may be entered and stored into a patient record either within the memory of programmer 420, or at data center 462.
- the information may further be employed to configure one or more IMD functions or systems automatically based on lead types, and/or may also be used to calibrate sensor circuits in ways similar to those discussed above.
- a transmitter/receiver such as transmitter/receiver 380
- FIG. 5 may instead be resident in PDM 420' .
- This transmitter/receiver may interrogate all lead components interconnected to the various IMDs to determine lead types, serial numbers, any sensor calibration values, and to communicate this information to programmer 420.
- Programmer may then program any or all of the IMDs to properly configure the IMD configurations. Alternatively, this configuration function may be performed by the processing circuit associated with each IMD.
- the foregoing examples describe several embodiments of the inventive recognition and configuration system and method, although it will be understood that modifications are possible within the scope of the current invention.
- the foregoing examples discuss a system that is powered using a remote energy source and an energy coupler as shown in Figure 6.
- Other types of power systems may be utilized, however.
- transponder 262 is not passive, but instead receives power by loosely coupling off of electrical therapy output of an IMD.
- FIG. 8 is a circuit diagram illustrating a transponder 498 coupled to the therapy output energy source of IMD 500.
- IMD 500 is shown coupled to a lead that includes two conductors 504 and 506. These conductors are coupled to a bridge circuit that includes capacitor 508.
- This capacitor is charged by one or more pulse signals generated by IMD 500 during, for example, the delivery of pacing therapies or other pulsed stimulation therapies.
- the pulsed signals 509 include a position and a negative phase such that during a portion of the signal, the voltage at point 510 is more position than at point 512, and in a different portion of the signal, the voltage polarity is reverse. In the former instance, current flows through diodes 514 and 516, and in the later instance current flows through diodes 518 and 520.
- capacitor 510 is charged in the manner shown.
- capacitor 510 is charged by the occurrence of multiple pulsed signals. For example, ten or more pulses may be required to completely charge the capacitor.
- the values of resistors 522 and 524 are selected to prevent the capacitor circuit from presenting an unduly large load that would affect the therapy delivery of IMD 500.
- Capacitors 526 and 528 may be provided to prevent a DC offset voltage potential from being present across conductors 504 and 506, which may promote corrosion of any electrodes that are carried by the lead.
- the capacitor circuit is coupled to only a single lead conductor, with the second connection being provided via the IMD and transponder cans, as indicated by dashed line 530.
- transponder 498 may be intermittently operated to provide a brief burst of modulated RF energy from the transmitter of the transponder.
- the receiver of the transponder could be intermittently powered to receive information from the IMD or another source. This embodiment would allow for longer- range communications than is provided by the passively-powered embodiment.
- SAW surface acoustic wave
- This type of filter includes an SAW delay line.
- An RF signal is transmitted from an interrogation unit such as transmitter/receiver circuit 380 of Figure 6, and is received by an antenna residing in the transponder that is coupled to the delay line.
- the signal is provided to the delay line, which includes predetermined discontinuities that result in signal reflections.
- the unique signal reflections which are a result of the selected configuration of the delay line, can be interpreted as a signature which may be transmitted to the interrogation unit for interpretation.
- the signature may encode a serial number, or any other type of information.
- the SAW filter thereby serves as a nonvolatile storage device not unlike a hard-wired switch.
- This filter may be used in place of, or in addition to, storage devices such as storage device 394 of Figure 6.
- data stored within a transponder 362 of a component is employed by an IMD to configure circuitry within the component.
- a lead may include data interface to couple to an interface of the IMD.
- a processing circuit such as micro-computer circuit 302 is capable of transferring signals via the data interface to configure circuitry of the lead.
- the processing circuit may store data within a programmable device such as a register provided by the lead, thereby configuring the lead for operation with the IMD.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02756583A EP1409075B1 (en) | 2001-07-17 | 2002-07-10 | Automatic implantable medical lead recognition and configuration |
JP2003513639A JP4299661B2 (en) | 2001-07-17 | 2002-07-10 | Method and apparatus for automatically recognizing and setting implantable medical leads |
CA002454020A CA2454020A1 (en) | 2001-07-17 | 2002-07-10 | Automatic implantable medical lead recognition and configuration |
DE60223146T DE60223146T2 (en) | 2001-07-17 | 2002-07-10 | AUTOMATIC RECOGNITION AND CONFIGURATION OF IMPLANTABLE MEDICAL LINES |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/907,308 | 2001-07-17 | ||
US09/907,308 US6675049B2 (en) | 2001-07-17 | 2001-07-17 | Method and apparatus for automatic implantable medical lead recognition and configuration |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003008037A2 true WO2003008037A2 (en) | 2003-01-30 |
WO2003008037A3 WO2003008037A3 (en) | 2003-05-22 |
Family
ID=25423877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/023294 WO2003008037A2 (en) | 2001-07-17 | 2002-07-10 | Automatic implantable medical lead recognition and configuration |
Country Status (6)
Country | Link |
---|---|
US (3) | US6675049B2 (en) |
EP (1) | EP1409075B1 (en) |
JP (1) | JP4299661B2 (en) |
CA (1) | CA2454020A1 (en) |
DE (1) | DE60223146T2 (en) |
WO (1) | WO2003008037A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1618829A1 (en) * | 2003-04-25 | 2006-01-25 | Olympus Corporation | Radio-type in-subject information acquisition system, device for introduction into subject, and outside-subject device |
US7060030B2 (en) | 2002-01-08 | 2006-06-13 | Cardiac Pacemakers, Inc. | Two-hop telemetry interface for medical device |
JP2007529274A (en) * | 2004-03-15 | 2007-10-25 | カーディアック・ペースメーカーズ・インコーポレーテッド | Secure authentication of data exchange sessions using implantable medical devices |
WO2009105646A1 (en) * | 2008-02-21 | 2009-08-27 | Boston Scientific Neuromodulation Corporation | Temporary neurostimulation lead identification device |
Families Citing this family (222)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030036746A1 (en) * | 2001-08-16 | 2003-02-20 | Avi Penner | Devices for intrabody delivery of molecules and systems and methods utilizing same |
US7198603B2 (en) * | 2003-04-14 | 2007-04-03 | Remon Medical Technologies, Inc. | Apparatus and methods using acoustic telemetry for intrabody communications |
US7024248B2 (en) * | 2000-10-16 | 2006-04-04 | Remon Medical Technologies Ltd | Systems and methods for communicating with implantable devices |
US20070173911A1 (en) * | 2001-02-20 | 2007-07-26 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US6949929B2 (en) * | 2003-06-24 | 2005-09-27 | Biophan Technologies, Inc. | Magnetic resonance imaging interference immune device |
US20070168006A1 (en) * | 2001-02-20 | 2007-07-19 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050283167A1 (en) * | 2003-08-25 | 2005-12-22 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050283214A1 (en) * | 2003-08-25 | 2005-12-22 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050288753A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20070168005A1 (en) * | 2001-02-20 | 2007-07-19 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US6829509B1 (en) * | 2001-02-20 | 2004-12-07 | Biophan Technologies, Inc. | Electromagnetic interference immune tissue invasive system |
US6662048B2 (en) | 2001-03-30 | 2003-12-09 | Cardiac Pacemakers, Inc. | Implantable medical device with temperature measuring and storing capability |
US10576275B2 (en) | 2001-07-06 | 2020-03-03 | Cochlear Limited | System and method for configuring an external device using operating parameters from an implanted device |
US7903043B2 (en) * | 2003-12-22 | 2011-03-08 | Cardiac Pacemakers, Inc. | Radio frequency antenna in a header of an implantable medical device |
DE10155413A1 (en) * | 2001-11-10 | 2003-05-22 | Bosch Gmbh Robert | Valve for controlling liquids |
US7853330B2 (en) | 2001-12-04 | 2010-12-14 | Boston Scientific Neuromodulation Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US6993384B2 (en) * | 2001-12-04 | 2006-01-31 | Advanced Bionics Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US6993393B2 (en) | 2001-12-19 | 2006-01-31 | Cardiac Pacemakers, Inc. | Telemetry duty cycle management system for an implantable medical device |
US7729776B2 (en) | 2001-12-19 | 2010-06-01 | Cardiac Pacemakers, Inc. | Implantable medical device with two or more telemetry systems |
US7096068B2 (en) * | 2002-01-17 | 2006-08-22 | Cardiac Pacemakers, Inc. | User-attachable or detachable telemetry module for medical devices |
US6985773B2 (en) | 2002-02-07 | 2006-01-10 | Cardiac Pacemakers, Inc. | Methods and apparatuses for implantable medical device telemetry power management |
US7239920B1 (en) * | 2002-02-12 | 2007-07-03 | Advanced Bionics Corporation | Neural stimulation system providing auto adjustment of stimulus output as a function of sensed pressure changes |
US20030153959A1 (en) * | 2002-02-12 | 2003-08-14 | Thacker James R. | Neural stimulation system providing auto adjustment of stimulus output as a function of sensed coupling efficiency |
US7317948B1 (en) * | 2002-02-12 | 2008-01-08 | Boston Scientific Scimed, Inc. | Neural stimulation system providing auto adjustment of stimulus output as a function of sensed impedance |
US7069086B2 (en) * | 2002-08-08 | 2006-06-27 | Cardiac Pacemakers, Inc. | Method and system for improved spectral efficiency of far field telemetry in a medical device |
US7901419B2 (en) * | 2002-09-04 | 2011-03-08 | Allergan, Inc. | Telemetrically controlled band for regulating functioning of a body organ or duct, and methods of making, implantation and use |
US7127300B2 (en) * | 2002-12-23 | 2006-10-24 | Cardiac Pacemakers, Inc. | Method and apparatus for enabling data communication between an implantable medical device and a patient management system |
US20040162586A1 (en) * | 2003-02-18 | 2004-08-19 | Covey Kevin K. | Defibrillator electrodes with identification tags |
US20060102871A1 (en) * | 2003-04-08 | 2006-05-18 | Xingwu Wang | Novel composition |
US7388378B2 (en) * | 2003-06-24 | 2008-06-17 | Medtronic, Inc. | Magnetic resonance imaging interference immune device |
US7839146B2 (en) * | 2003-06-24 | 2010-11-23 | Medtronic, Inc. | Magnetic resonance imaging interference immune device |
US7494459B2 (en) * | 2003-06-26 | 2009-02-24 | Biophan Technologies, Inc. | Sensor-equipped and algorithm-controlled direct mechanical ventricular assist device |
US20060167334A1 (en) * | 2003-06-26 | 2006-07-27 | Anstadt Mark P | Method and apparatus for direct mechanical ventricular actuation with favorable conditioning and minimal heart stress |
US20050027204A1 (en) * | 2003-06-26 | 2005-02-03 | Kligfield Paul D. | ECG diagnostic system and method |
US20050050042A1 (en) * | 2003-08-20 | 2005-03-03 | Marvin Elder | Natural language database querying |
US8868212B2 (en) * | 2003-08-25 | 2014-10-21 | Medtronic, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050288751A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050288756A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050049688A1 (en) * | 2003-08-25 | 2005-03-03 | Biophan Technologies, Inc. | Electromagnetic radiation transparent device and method of making thereof |
US20050288752A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050288755A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050288754A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050283213A1 (en) * | 2003-08-25 | 2005-12-22 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
DE10341007B4 (en) * | 2003-09-05 | 2005-12-08 | Leuze Lumiflex Gmbh + Co. Kg | Light barrier arrangement |
US20050192838A1 (en) * | 2004-02-27 | 2005-09-01 | Cardiac Pacemakers, Inc. | Systems and methods for accessing and distributing medical information |
US20050192843A1 (en) * | 2004-02-27 | 2005-09-01 | Cardiac Pacemakers, Inc. | Systems and methods for validating patient and medical devices information |
US20050192837A1 (en) * | 2004-02-27 | 2005-09-01 | Cardiac Pacemakers, Inc. | Systems and methods for uploading and distributing medical data sets |
US7359753B2 (en) | 2004-04-07 | 2008-04-15 | Cardiac Pacemakers, Inc. | System and method for RF wake-up of implantable medical device |
US7240833B2 (en) * | 2004-05-20 | 2007-07-10 | Cardiac Pacemakers, Inc. | System and method of managing information for an implantable medical device |
US7794499B2 (en) * | 2004-06-08 | 2010-09-14 | Theken Disc, L.L.C. | Prosthetic intervertebral spinal disc with integral microprocessor |
US7346382B2 (en) | 2004-07-07 | 2008-03-18 | The Cleveland Clinic Foundation | Brain stimulation models, systems, devices, and methods |
WO2006012371A1 (en) * | 2004-07-20 | 2006-02-02 | Medtronic, Inc. | Concurrent delivery of treatment therapy with telemetry in an implantable medical device |
WO2006023700A2 (en) * | 2004-08-20 | 2006-03-02 | Biophan Technologies, Inc. | Magnetic resonance imaging interference immune device |
US20060064142A1 (en) | 2004-09-17 | 2006-03-23 | Cardiac Pacemakers, Inc. | Systems and methods for deriving relative physiologic measurements using an implanted sensor device |
US7720546B2 (en) * | 2004-09-30 | 2010-05-18 | Codman Neuro Sciences Sárl | Dual power supply switching circuitry for use in a closed system |
US7650186B2 (en) | 2004-10-20 | 2010-01-19 | Boston Scientific Scimed, Inc. | Leadless cardiac stimulation systems |
WO2006045075A1 (en) | 2004-10-20 | 2006-04-27 | Boston Scientific Limited | Leadless cardiac stimulation systems |
US7532933B2 (en) | 2004-10-20 | 2009-05-12 | Boston Scientific Scimed, Inc. | Leadless cardiac stimulation systems |
US20060106561A1 (en) * | 2004-11-12 | 2006-05-18 | Michelin Recherche Et Technique S.A. | Centralized calibration coefficients for sensor based measurements |
US7813808B1 (en) | 2004-11-24 | 2010-10-12 | Remon Medical Technologies Ltd | Implanted sensor system with optimized operational and sensing parameters |
US7218969B2 (en) * | 2005-01-19 | 2007-05-15 | Cardiac Pacemakers, Inc. | Dynamic channel selection for RF telemetry with implantable device |
US7545272B2 (en) * | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
US7610065B2 (en) * | 2005-02-28 | 2009-10-27 | Cardiac Pacemakers, Inc. | Method and apparatus for antenna selection in a diversity antenna system for communicating with implantable medical device |
US8131357B2 (en) * | 2005-04-01 | 2012-03-06 | Boston Scientific Neuromodulation Corporation | Apparatus and methods for detecting migration of neurostimulation leads |
US8112154B2 (en) * | 2005-04-13 | 2012-02-07 | The Cleveland Clinic Foundation | Systems and methods for neuromodulation using pre-recorded waveforms |
US9339650B2 (en) | 2005-04-13 | 2016-05-17 | The Cleveland Clinic Foundation | Systems and methods for neuromodulation using pre-recorded waveforms |
US7657317B2 (en) | 2005-04-26 | 2010-02-02 | Boston Scientific Neuromodulation Corporation | Evaluating stimulation therapies and patient satisfaction |
US7664553B2 (en) | 2005-04-27 | 2010-02-16 | Cardiac Pacemakers, Inc. | System and method for enabling communications with implantable medical devices |
US20070038285A1 (en) * | 2005-05-19 | 2007-02-15 | Biophan Technologies, Inc. | Electromagnetic resonant circuit sleeve for implantable medical device |
US7801620B2 (en) * | 2005-08-29 | 2010-09-21 | Cardiac Pacemakers, Inc. | RF telemetry link quality assessment system and method |
US8027727B2 (en) * | 2005-08-29 | 2011-09-27 | Cardiac Pacemakers, Inc. | Pacemaker RF telemetry repeater and method |
US7742815B2 (en) * | 2005-09-09 | 2010-06-22 | Cardiac Pacemakers, Inc. | Using implanted sensors for feedback control of implanted medical devices |
US8380320B2 (en) * | 2005-09-12 | 2013-02-19 | Medtronic, Inc. | Implantable medical device communication system with macro and micro sampling intervals |
US8065018B2 (en) | 2005-09-12 | 2011-11-22 | Medtronic, Inc. | System and method for unscheduled wireless communication with a medical device |
US8185210B2 (en) * | 2005-09-12 | 2012-05-22 | Medtronic, Inc. | Communication system and method with preamble encoding for an implantable medical device |
US7890181B2 (en) * | 2005-09-12 | 2011-02-15 | Medtronic, Inc. | System and method for unscheduled wireless communication with a medical device |
US8160704B2 (en) * | 2005-11-02 | 2012-04-17 | Cardiac Pacemakers, Inc. | System and method for enabling relayed communications by implantable medical devices |
WO2007102893A2 (en) * | 2005-11-11 | 2007-09-13 | Greatbatch Ltd. | Tank filters placed in series with the lead wires or circuits of active medical devices to enhance mri compatibility |
EP1957160A2 (en) * | 2005-11-28 | 2008-08-20 | Myotech LLC | Method and apparatus for minimally invasive direct mechanical ventricular actuation |
JP2009518115A (en) | 2005-12-09 | 2009-05-07 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Heart stimulation system |
US20070203547A1 (en) * | 2005-12-15 | 2007-08-30 | Costello Benedict J | Medical device identification |
AT502985B1 (en) * | 2005-12-22 | 2009-05-15 | Lechner Wolfgang Dr | SYSTEM FOR CONTROLLING A CONTROLLABLE MAGNETIC STRIP |
US8050774B2 (en) | 2005-12-22 | 2011-11-01 | Boston Scientific Scimed, Inc. | Electrode apparatus, systems and methods |
USRE49527E1 (en) * | 2006-02-10 | 2023-05-16 | Cochlear Limited | Recognition of implantable medical device |
US7937161B2 (en) | 2006-03-31 | 2011-05-03 | Boston Scientific Scimed, Inc. | Cardiac stimulation electrodes, delivery devices, and implantation configurations |
US8805526B2 (en) * | 2006-05-03 | 2014-08-12 | Cardiac Pacemakers, Inc. | Configurable medical telemetry radio system |
US7727143B2 (en) * | 2006-05-31 | 2010-06-01 | Allergan, Inc. | Locator system for implanted access port with RFID tag |
US20070298487A1 (en) * | 2006-06-23 | 2007-12-27 | Becton, Dickinson And Company | Radio Frequency Transponder Assay |
US8185204B2 (en) | 2006-07-12 | 2012-05-22 | Cardiac Pacemakers, Inc. | Implantable medical device telemetry with adaptive frequency hopping |
US7623922B2 (en) * | 2006-07-12 | 2009-11-24 | Cardiac Pacemakers, Inc. | Implantable medical device telemetry with periodic frequency hopping |
US7955268B2 (en) | 2006-07-21 | 2011-06-07 | Cardiac Pacemakers, Inc. | Multiple sensor deployment |
US8290600B2 (en) * | 2006-07-21 | 2012-10-16 | Boston Scientific Scimed, Inc. | Electrical stimulation of body tissue using interconnected electrode assemblies |
US7840281B2 (en) | 2006-07-21 | 2010-11-23 | Boston Scientific Scimed, Inc. | Delivery of cardiac stimulation devices |
US7908334B2 (en) * | 2006-07-21 | 2011-03-15 | Cardiac Pacemakers, Inc. | System and method for addressing implantable devices |
US20080077440A1 (en) * | 2006-09-26 | 2008-03-27 | Remon Medical Technologies, Ltd | Drug dispenser responsive to physiological parameters |
US7630768B1 (en) * | 2006-10-04 | 2009-12-08 | Greatbatch Ltd. | One-piece header assembly for an implantable medical device and methods for making same |
US7717754B2 (en) * | 2006-12-07 | 2010-05-18 | Medtronic, Inc. | Connector assembly with internal seals and manufacturing method |
US8768486B2 (en) | 2006-12-11 | 2014-07-01 | Medtronic, Inc. | Medical leads with frequency independent magnetic resonance imaging protection |
US20080201088A1 (en) * | 2007-02-20 | 2008-08-21 | Atmel Corporation | System and method for monitoring a process |
US8046079B2 (en) | 2007-03-13 | 2011-10-25 | Cardiac Pacemakers, Inc. | Implantable medical device telemetry with hop-on-error frequency hopping |
KR20090128499A (en) * | 2007-03-19 | 2009-12-15 | 인슐린 메디컬 엘티디 | Drug delivery device |
EP2136863A2 (en) * | 2007-03-19 | 2009-12-30 | Insuline Medical Ltd. | Device for drug delivery and associated connections thereto |
US9220837B2 (en) * | 2007-03-19 | 2015-12-29 | Insuline Medical Ltd. | Method and device for drug delivery |
US8622991B2 (en) * | 2007-03-19 | 2014-01-07 | Insuline Medical Ltd. | Method and device for drug delivery |
US20080281305A1 (en) * | 2007-05-10 | 2008-11-13 | Cardiac Pacemakers, Inc. | Method and apparatus for relieving angina symptoms using light |
AU2008262127A1 (en) * | 2007-06-14 | 2008-12-18 | Cardiac Pacemakers, Inc. | Intracorporeal pressure measurement devices and methods |
US8731669B2 (en) * | 2007-06-19 | 2014-05-20 | Medtronic, Inc. | Bipolar lead containing HV and LV signal capability |
US20090137890A1 (en) * | 2007-11-27 | 2009-05-28 | Burnes John E | Devices to monitor glucose levels and ischemia |
EP2231229A1 (en) | 2007-12-18 | 2010-09-29 | Insuline Medical Ltd. | Drug delivery device with sensor for closed-loop operation |
US8041431B2 (en) * | 2008-01-07 | 2011-10-18 | Cardiac Pacemakers, Inc. | System and method for in situ trimming of oscillators in a pair of implantable medical devices |
US8301262B2 (en) * | 2008-02-06 | 2012-10-30 | Cardiac Pacemakers, Inc. | Direct inductive/acoustic converter for implantable medical device |
JP5153892B2 (en) | 2008-02-07 | 2013-02-27 | カーディアック ペースメイカーズ, インコーポレイテッド | Wireless tissue electrical stimulation |
US8725260B2 (en) * | 2008-02-11 | 2014-05-13 | Cardiac Pacemakers, Inc | Methods of monitoring hemodynamic status for rhythm discrimination within the heart |
US8255055B2 (en) * | 2008-02-11 | 2012-08-28 | Cardiac Pacemakers, Inc. | MRI shielding in electrodes using AC pacing |
US9220889B2 (en) | 2008-02-11 | 2015-12-29 | Intelect Medical, Inc. | Directional electrode devices with locating features |
US8019440B2 (en) | 2008-02-12 | 2011-09-13 | Intelect Medical, Inc. | Directional lead assembly |
US8369960B2 (en) * | 2008-02-12 | 2013-02-05 | Cardiac Pacemakers, Inc. | Systems and methods for controlling wireless signal transfers between ultrasound-enabled medical devices |
US8554331B2 (en) * | 2008-04-29 | 2013-10-08 | Medtronic, Inc. | Therapy program modification |
US9272153B2 (en) | 2008-05-15 | 2016-03-01 | Boston Scientific Neuromodulation Corporation | VOA generation system and method using a fiber specific analysis |
US8126566B2 (en) * | 2008-08-14 | 2012-02-28 | Cardiac Pacemakers, Inc. | Performance assessment and adaptation of an acoustic communication link |
EP2334230A1 (en) * | 2008-10-10 | 2011-06-22 | Cardiac Pacemakers, Inc. | Systems and methods for determining cardiac output using pulmonary artery pressure measurements |
US20100106215A1 (en) * | 2008-10-23 | 2010-04-29 | Stubbs Scott R | Systems and methods to detect implantable medical device configuaration changes affecting mri conditional safety |
BRPI0916125A2 (en) | 2008-11-07 | 2015-11-03 | Insuline Medical Ltd | "treatment device" |
WO2010059291A1 (en) | 2008-11-19 | 2010-05-27 | Cardiac Pacemakers, Inc. | Assessment of pulmonary vascular resistance via pulmonary artery pressure |
US9724508B2 (en) * | 2009-03-09 | 2017-08-08 | Boston Scientific Neuromodulation Corporation | Electronic identification of external cables for external medical devices |
US9084883B2 (en) | 2009-03-12 | 2015-07-21 | Cardiac Pacemakers, Inc. | Thin profile conductor assembly for medical device leads |
US20100274115A1 (en) * | 2009-04-24 | 2010-10-28 | Medtronic, Inc. | Lead extension with physiological data recorder |
US10130282B2 (en) | 2009-04-30 | 2018-11-20 | Medtronic, Inc. | Verification that a patient with an implantable medical system can undergo a magnetic resonance imaging scan |
US20100324378A1 (en) * | 2009-06-17 | 2010-12-23 | Tran Binh C | Physiologic signal monitoring using ultrasound signals from implanted devices |
US8527054B2 (en) * | 2009-06-30 | 2013-09-03 | Richard B. North | Implantable medical device connector |
US8521290B2 (en) * | 2009-06-30 | 2013-08-27 | Richard B. North | Implantable medical device connector |
US8388582B2 (en) | 2009-08-12 | 2013-03-05 | Medrad, Inc. | Systems and methods for operating interventional catheters using a common operating console and adaptive interface components |
US9072540B2 (en) | 2009-08-12 | 2015-07-07 | Boston Scientific Limited | Adaptive tubing cassettes for use in connection with interventional catheter assemblies |
EP2470258B1 (en) | 2009-08-27 | 2017-03-15 | The Cleveland Clinic Foundation | System and method to estimate region of tissue activation |
US8369964B2 (en) * | 2009-10-09 | 2013-02-05 | Cardiac Pacemakers, Inc. | MRI compatible medical device lead including transmission line notch filters |
WO2011049684A1 (en) | 2009-10-19 | 2011-04-28 | Cardiac Pacemakers, Inc. | Mri compatible tachycardia lead |
WO2011068997A1 (en) | 2009-12-02 | 2011-06-09 | The Cleveland Clinic Foundation | Reversing cognitive-motor impairments in patients having a neuro-degenerative disease using a computational modeling approach to deep brain stimulation programming |
AU2010337309B2 (en) | 2009-12-30 | 2014-01-23 | Cardiac Pacemakers, Inc. | MRI-conditionally safe medical device lead |
WO2011081697A1 (en) * | 2009-12-30 | 2011-07-07 | Cardiac Pacemakers, Inc. | Apparatus to selectively increase medical device lead inner conductor inductance |
US8406895B2 (en) * | 2009-12-30 | 2013-03-26 | Cardiac Pacemakers, Inc. | Implantable electrical lead including a cooling assembly to dissipate MRI induced electrode heat |
US8391994B2 (en) | 2009-12-31 | 2013-03-05 | Cardiac Pacemakers, Inc. | MRI conditionally safe lead with low-profile multi-layer conductor for longitudinal expansion |
US8798767B2 (en) | 2009-12-31 | 2014-08-05 | Cardiac Pacemakers, Inc. | MRI conditionally safe lead with multi-layer conductor |
US20110196189A1 (en) * | 2010-02-09 | 2011-08-11 | Myocardiocare, Inc. | Extra-cardiac differential ventricular actuation by inertial and baric partitioning |
WO2011136917A1 (en) | 2010-04-29 | 2011-11-03 | Cardiac Pacemakers, Inc. | Implantable medical device configuration based on port usage |
US20110270025A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Remotely powered remotely adjustable gastric band system |
EP2580710B1 (en) | 2010-06-14 | 2016-11-09 | Boston Scientific Neuromodulation Corporation | Programming interface for spinal cord neuromodulation |
US8825181B2 (en) | 2010-08-30 | 2014-09-02 | Cardiac Pacemakers, Inc. | Lead conductor with pitch and torque control for MRI conditionally safe use |
US20120123496A1 (en) * | 2010-11-12 | 2012-05-17 | Medtronic, Inc. | Connectivity detection and type identification of an implanted lead for an implantable medical device |
US8292842B2 (en) | 2011-03-25 | 2012-10-23 | Medtronic, Inc. | Automatically indentifying therapy delivery component connected to implantable medical device |
EP2691899A2 (en) | 2011-03-29 | 2014-02-05 | Boston Scientific Neuromodulation Corporation | System and method for leadwire location |
US8355784B2 (en) | 2011-05-13 | 2013-01-15 | Medtronic, Inc. | Dynamic representation of multipolar leads in a programmer interface |
US8945209B2 (en) | 2011-05-20 | 2015-02-03 | Edwards Lifesciences Corporation | Encapsulated heart valve |
US9592389B2 (en) | 2011-05-27 | 2017-03-14 | Boston Scientific Neuromodulation Corporation | Visualization of relevant stimulation leadwire electrodes relative to selected stimulation information |
US8798768B2 (en) | 2011-06-30 | 2014-08-05 | Greatbatch Ltd. | Electrically identifiable electrode lead and method of electrically identifying an electrode lead |
US9925382B2 (en) | 2011-08-09 | 2018-03-27 | Boston Scientific Neuromodulation Corporation | Systems and methods for stimulation-related volume analysis, creation, and sharing |
WO2013130421A1 (en) | 2012-02-29 | 2013-09-06 | The Cleveland Clinic Foundation | System and method for neuromodulation using composite patterns of stimulation or waveforms |
WO2013159031A2 (en) | 2012-04-20 | 2013-10-24 | Cardiac Pacemakers, Inc. | Implantable medical device lead including a unifilar coiled cable |
EP2841156A1 (en) | 2012-04-26 | 2015-03-04 | Medtronic, Inc. | Trial stimulation systems |
EP2841150B1 (en) | 2012-04-26 | 2020-09-30 | Medtronic, Inc. | Trial stimulation systems |
WO2013162709A1 (en) | 2012-04-26 | 2013-10-31 | Medtronic, Inc. | Trial stimulation systems |
US8954168B2 (en) | 2012-06-01 | 2015-02-10 | Cardiac Pacemakers, Inc. | Implantable device lead including a distal electrode assembly with a coiled component |
EP2879757B1 (en) | 2012-08-04 | 2019-06-26 | Boston Scientific Neuromodulation Corporation | Systems and methods for storing and transferring registration, atlas, and lead information between medical devices |
EP2890454B1 (en) | 2012-08-28 | 2017-11-08 | Boston Scientific Neuromodulation Corporation | Point-and-click programming for deep brain stimulation using real-time monopolar review trendlines |
CN104812437B (en) | 2012-08-31 | 2016-11-16 | 心脏起搏器股份公司 | The compatible lead loop of MRI |
WO2014062966A1 (en) | 2012-10-18 | 2014-04-24 | Cardiac Pacemakers, Inc. | Inductive element for providing mri compatibility in an implantable medical device lead |
WO2014070290A2 (en) | 2012-11-01 | 2014-05-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for voa model generation and use |
US9067073B2 (en) | 2013-05-06 | 2015-06-30 | Cardiac Pacemakers, Inc. | Method and apparatus for storing up-to-date information on an implantable medical device |
US9248294B2 (en) | 2013-09-11 | 2016-02-02 | Medtronic, Inc. | Method and apparatus for optimization of cardiac resynchronization therapy using vectorcardiograms derived from implanted electrodes |
US9387333B2 (en) * | 2013-09-17 | 2016-07-12 | Vassilis Dimas | Identifier device for implantable defibrillators and pacemakers |
US9724527B2 (en) | 2013-09-27 | 2017-08-08 | Cardiac Pacemakers, Inc. | Color coded header bore identification using multiple images and lens arrangement |
US9717905B2 (en) | 2013-09-30 | 2017-08-01 | Advanced Bionics Ag | Backup sound processor with multi-user functionality |
US9764139B2 (en) | 2014-01-24 | 2017-09-19 | Medtronic, Inc. | Pre-implant detection |
JP6244469B2 (en) | 2014-02-26 | 2017-12-06 | カーディアック ペースメイカーズ, インコーポレイテッド | MRI-safe tachycardia lead |
US20160015285A1 (en) * | 2014-07-17 | 2016-01-21 | Drexel University | Optoelectronic remotely powered silicon based hybrid neural electrode |
US9959388B2 (en) | 2014-07-24 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for providing electrical stimulation therapy feedback |
US10265528B2 (en) | 2014-07-30 | 2019-04-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for electrical stimulation-related patient population volume analysis and use |
US10272247B2 (en) | 2014-07-30 | 2019-04-30 | Boston Scientific Neuromodulation Corporation | Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming |
EP3180071B1 (en) | 2014-08-15 | 2021-09-22 | Axonics, Inc. | External pulse generator device and associated system for trial nerve stimulation |
WO2016057544A1 (en) | 2014-10-07 | 2016-04-14 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters |
US10105539B2 (en) | 2014-12-17 | 2018-10-23 | Cochlear Limited | Configuring a stimulation unit of a hearing device |
US9956393B2 (en) | 2015-02-24 | 2018-05-01 | Elira, Inc. | Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch |
US10335302B2 (en) | 2015-02-24 | 2019-07-02 | Elira, Inc. | Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions |
US20220062621A1 (en) | 2015-02-24 | 2022-03-03 | Elira, Inc. | Electrical Stimulation-Based Weight Management System |
US10765863B2 (en) | 2015-02-24 | 2020-09-08 | Elira, Inc. | Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy |
US10864367B2 (en) | 2015-02-24 | 2020-12-15 | Elira, Inc. | Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions |
EP3261712B1 (en) | 2015-02-24 | 2024-04-03 | Elira, Inc. | System for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch |
US10376145B2 (en) | 2015-02-24 | 2019-08-13 | Elira, Inc. | Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch |
US10780283B2 (en) | 2015-05-26 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
EP3268082B1 (en) | 2015-05-26 | 2019-04-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
EP3280490B1 (en) | 2015-06-29 | 2021-09-01 | Boston Scientific Neuromodulation Corporation | Systems for selecting stimulation parameters based on stimulation target region, effects, or side effects |
EP3280491B1 (en) | 2015-06-29 | 2023-03-01 | Boston Scientific Neuromodulation Corporation | Systems for selecting stimulation parameters by targeting and steering |
US10080653B2 (en) | 2015-09-10 | 2018-09-25 | Edwards Lifesciences Corporation | Limited expansion heart valve |
WO2017062378A1 (en) | 2015-10-09 | 2017-04-13 | Boston Scientific Neuromodulation Corporation | System and methods for clinical effects mapping for directional stimulations leads |
US10667904B2 (en) | 2016-03-08 | 2020-06-02 | Edwards Lifesciences Corporation | Valve implant with integrated sensor and transmitter |
US11478652B2 (en) * | 2016-03-17 | 2022-10-25 | Pacesetter Inc. | Implantable medical device with modular injection molded header assembly and related methods of manufacture |
US10716942B2 (en) | 2016-04-25 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | System and methods for directional steering of electrical stimulation |
CN109475741B (en) | 2016-05-31 | 2022-09-27 | 美敦力公司 | Electrogram-based control of cardiac resynchronization therapy |
AU2017281934B2 (en) | 2016-06-24 | 2019-11-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for visual analytics of clinical effects |
EP3269423A1 (en) * | 2016-07-13 | 2018-01-17 | BIOTRONIK SE & Co. KG | Implantable medical device with antenna for wireless communication |
US10602284B2 (en) | 2016-07-18 | 2020-03-24 | Cochlear Limited | Transducer management |
EP3284517B1 (en) * | 2016-08-16 | 2019-10-02 | BIOTRONIK SE & Co. KG | Implant and method for the identification of an electrode lead |
EP3284511B1 (en) | 2016-08-16 | 2021-06-09 | BIOTRONIK SE & Co. KG | Electrode lead, implant and method for the identification of an electrode lead |
EP3284510B1 (en) | 2016-08-16 | 2020-11-11 | BIOTRONIK SE & Co. KG | Electrode lead, implant and method for the identification of an electrode lead |
EP3284508B1 (en) | 2016-08-16 | 2019-07-17 | BIOTRONIK SE & Co. KG | Implant and method for the identification of an electrode lead |
WO2018044881A1 (en) | 2016-09-02 | 2018-03-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and directing stimulation of neural elements |
US10780282B2 (en) | 2016-09-20 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters |
CN109803719B (en) | 2016-10-14 | 2023-05-26 | 波士顿科学神经调制公司 | System and method for closed loop determination of stimulation parameter settings for an electrical simulation system |
WO2018089311A1 (en) | 2016-11-08 | 2018-05-17 | Cardiac Pacemakers, Inc | Implantable medical device for atrial deployment |
JP6834005B2 (en) | 2017-01-03 | 2021-02-24 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Systems and methods for selecting MRI-matched stimulus parameters |
ES2821752T3 (en) | 2017-01-10 | 2021-04-27 | Boston Scient Neuromodulation Corp | Systems and procedures for creating stimulation programs based on user-defined areas or volumes |
US10625082B2 (en) | 2017-03-15 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Visualization of deep brain stimulation efficacy |
WO2018187090A1 (en) | 2017-04-03 | 2018-10-11 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating a volume of activation using a compressed database of threshold values |
US10463485B2 (en) | 2017-04-06 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic valve holders with automatic deploying mechanisms |
WO2018200681A1 (en) | 2017-04-28 | 2018-11-01 | Edwards Lifesciences Corporation | Prosthetic heart valve with collapsible holder |
WO2018237020A1 (en) | 2017-06-21 | 2018-12-27 | Edwards Lifesciences Corporation | Dual-wireform limited expansion heart valves |
EP3651849B1 (en) | 2017-07-14 | 2023-05-31 | Boston Scientific Neuromodulation Corporation | Estimating clinical effects of electrical stimulation |
EP3634569A1 (en) | 2017-08-15 | 2020-04-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for controlling electrical stimulation using multiple stimulation fields |
EP3784331B1 (en) | 2018-04-27 | 2023-01-18 | Boston Scientific Neuromodulation Corporation | Multi-mode electrical stimulation systems and methods of making and using |
US11285329B2 (en) | 2018-04-27 | 2022-03-29 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and programming electrical stimulation |
EP4076284A1 (en) | 2019-12-16 | 2022-10-26 | Edwards Lifesciences Corporation | Valve holder assembly with suture looping protection |
US11896812B1 (en) | 2023-01-27 | 2024-02-13 | Lifebridge Technologies Llc | Versatile modular heart pump for non-blood contacting ventricular function augmentation |
US11383076B2 (en) | 2020-10-01 | 2022-07-12 | Lifebridge Technologies, Llc | Pump regulation based on heart size and function |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3348548A (en) | 1965-04-26 | 1967-10-24 | William M Chardack | Implantable electrode with stiffening stylet |
US3754555A (en) | 1971-10-05 | 1973-08-28 | G Schmitt | Controllable barbed intracardial electrode |
US3814104A (en) | 1971-07-05 | 1974-06-04 | W Irnich | Pacemaker-electrode |
US3844292A (en) | 1972-06-09 | 1974-10-29 | Medtronic Inc | Intravascular lead assembly |
US3974834A (en) | 1975-04-23 | 1976-08-17 | Medtronic, Inc. | Body-implantable lead |
US5246014A (en) | 1991-11-08 | 1993-09-21 | Medtronic, Inc. | Implantable lead system |
US5397343A (en) | 1993-12-09 | 1995-03-14 | Medtronic, Inc. | Medical electrical lead having counter fixation anchoring system |
US6178355B1 (en) | 1997-04-29 | 2001-01-23 | Medtronic, Inc. | Intracardiac defibrillation leads |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4556063A (en) | 1980-10-07 | 1985-12-03 | Medtronic, Inc. | Telemetry system for a medical device |
US4374382A (en) | 1981-01-16 | 1983-02-15 | Medtronic, Inc. | Marker channel telemetry system for a medical device |
US4485813A (en) | 1981-11-19 | 1984-12-04 | Medtronic, Inc. | Implantable dynamic pressure transducer system |
US4543955A (en) | 1983-08-01 | 1985-10-01 | Cordis Corporation | System for controlling body implantable action device |
JPS60171475A (en) | 1984-02-15 | 1985-09-04 | アイデンティフィケ−ション・デバイセス・インコ−ポレ−テッド | Discriminating system |
US4628934A (en) | 1984-08-07 | 1986-12-16 | Cordis Corporation | Method and means of electrode selection for pacemaker with multielectrode leads |
US4821723A (en) | 1987-02-27 | 1989-04-18 | Intermedics Inc. | Biphasic waveforms for defibrillation |
US4886064A (en) | 1987-11-25 | 1989-12-12 | Siemens Aktiengesellschaft | Body activity controlled heart pacer |
US5144524A (en) | 1988-04-27 | 1992-09-01 | Hewlett-Packard Company | Light trap for blocking reflection and scattering of light |
US5052388A (en) | 1989-12-22 | 1991-10-01 | Medtronic, Inc. | Method and apparatus for implementing activity sensing in a pulse generator |
US5127404A (en) | 1990-01-22 | 1992-07-07 | Medtronic, Inc. | Telemetry format for implanted medical device |
US5025550A (en) | 1990-05-25 | 1991-06-25 | Trovan Limited | Automated method for the manufacture of small implantable transponder devices |
US5252962A (en) | 1990-08-03 | 1993-10-12 | Bio Medic Data Systems | System monitoring programmable implantable transponder |
US5154170A (en) | 1990-08-14 | 1992-10-13 | Medtronic, Inc. | Optimization for rate responsive cardiac pacemaker |
US5158078A (en) | 1990-08-14 | 1992-10-27 | Medtronic, Inc. | Rate responsive pacemaker and methods for optimizing its operation |
US6387052B1 (en) * | 1991-01-29 | 2002-05-14 | Edwards Lifesciences Corporation | Thermodilution catheter having a safe, flexible heating element |
US5207218A (en) | 1991-02-27 | 1993-05-04 | Medtronic, Inc. | Implantable pulse generator |
US5131388A (en) | 1991-03-14 | 1992-07-21 | Ventritex, Inc. | Implantable cardiac defibrillator with improved capacitors |
US5144949A (en) | 1991-03-15 | 1992-09-08 | Medtronic, Inc. | Dual chamber rate responsive pacemaker with automatic mode switching |
US5199428A (en) | 1991-03-22 | 1993-04-06 | Medtronic, Inc. | Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload |
DE69210395T2 (en) | 1991-04-05 | 1997-01-09 | Medtronic Inc | DETECTION SYSTEM WITH SUBCUTANEOUS MULTIPLE ELECTRODES |
US5281855A (en) | 1991-06-05 | 1994-01-25 | Trovan Limited | Integrated circuit device including means for facilitating connection of antenna lead wires to an integrated circuit die |
US5383874A (en) * | 1991-11-08 | 1995-01-24 | Ep Technologies, Inc. | Systems for identifying catheters and monitoring their use |
US5271395A (en) | 1992-04-17 | 1993-12-21 | Medtronic, Inc. | Method and apparatus for rate-responsive cardiac pacing |
US5330507A (en) | 1992-04-24 | 1994-07-19 | Medtronic, Inc. | Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias |
US5312453A (en) | 1992-05-11 | 1994-05-17 | Medtronic, Inc. | Rate responsive cardiac pacemaker and method for work-modulating pacing rate deceleration |
US5374279A (en) | 1992-10-30 | 1994-12-20 | Medtronic, Inc. | Switchable connector block for implantable defibrillator |
US5499017A (en) | 1992-12-02 | 1996-03-12 | Avid | Multi-memory electronic identification tag |
US5354316A (en) | 1993-01-29 | 1994-10-11 | Medtronic, Inc. | Method and apparatus for detection and treatment of tachycardia and fibrillation |
US5423334A (en) | 1993-02-01 | 1995-06-13 | C. R. Bard, Inc. | Implantable medical device characterization system |
US5314430A (en) | 1993-06-24 | 1994-05-24 | Medtronic, Inc. | Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use |
EP0672427A1 (en) * | 1994-03-17 | 1995-09-20 | Siemens-Elema AB | System for infusion of medicine into the body of a patient |
US5782891A (en) | 1994-06-16 | 1998-07-21 | Medtronic, Inc. | Implantable ceramic enclosure for pacing, neurological, and other medical applications in the human body |
US5626630A (en) | 1994-10-13 | 1997-05-06 | Ael Industries, Inc. | Medical telemetry system using an implanted passive transponder |
US5534018A (en) | 1994-11-30 | 1996-07-09 | Medtronic, Inc. | Automatic lead recognition for implantable medical device |
US5545186A (en) | 1995-03-30 | 1996-08-13 | Medtronic, Inc. | Prioritized rule based method and apparatus for diagnosis and treatment of arrhythmias |
US5824030A (en) | 1995-12-21 | 1998-10-20 | Pacesetter, Inc. | Lead with inter-electrode spacing adjustment |
US5833603A (en) * | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
US5626623A (en) * | 1996-04-30 | 1997-05-06 | Medtronic, Inc. | Method and apparatus for optimizing pacemaker AV delay |
SE9602846D0 (en) | 1996-07-23 | 1996-07-23 | Pacesetter Ab | A stimulation device |
US6208894B1 (en) * | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
JP4149004B2 (en) | 1997-03-27 | 2008-09-10 | アルフレッド イー マン ファウンデーション フォア サイエンティフィック リサーチ | Implantable device system for monitoring and / or acting on body parameters |
US5919221A (en) | 1997-04-22 | 1999-07-06 | Medtronic, Inc | Method and apparatus for calibrating pacemaker pressure sensor lead prior to chronic implant |
US6409674B1 (en) * | 1998-09-24 | 2002-06-25 | Data Sciences International, Inc. | Implantable sensor with wireless communication |
US6016447A (en) | 1998-10-27 | 2000-01-18 | Medtronic, Inc. | Pacemaker implant recognition |
US6607485B2 (en) * | 1999-06-03 | 2003-08-19 | Cardiac Intelligence Corporation | Computer readable storage medium containing code for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care |
US6564105B2 (en) * | 2000-01-21 | 2003-05-13 | Medtronic Minimed, Inc. | Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data |
US7553280B2 (en) * | 2000-06-29 | 2009-06-30 | Sensors For Medicine And Science, Inc. | Implanted sensor processing system and method |
-
2001
- 2001-07-17 US US09/907,308 patent/US6675049B2/en not_active Expired - Lifetime
-
2002
- 2002-07-10 WO PCT/US2002/023294 patent/WO2003008037A2/en active IP Right Grant
- 2002-07-10 JP JP2003513639A patent/JP4299661B2/en not_active Expired - Fee Related
- 2002-07-10 CA CA002454020A patent/CA2454020A1/en not_active Abandoned
- 2002-07-10 DE DE60223146T patent/DE60223146T2/en not_active Expired - Lifetime
- 2002-07-10 EP EP02756583A patent/EP1409075B1/en not_active Expired - Lifetime
-
2003
- 2003-11-14 US US10/713,661 patent/US20040176822A1/en not_active Abandoned
- 2003-11-14 US US10/714,123 patent/US7239916B2/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3348548A (en) | 1965-04-26 | 1967-10-24 | William M Chardack | Implantable electrode with stiffening stylet |
US3814104A (en) | 1971-07-05 | 1974-06-04 | W Irnich | Pacemaker-electrode |
US3754555A (en) | 1971-10-05 | 1973-08-28 | G Schmitt | Controllable barbed intracardial electrode |
US3844292A (en) | 1972-06-09 | 1974-10-29 | Medtronic Inc | Intravascular lead assembly |
US3974834A (en) | 1975-04-23 | 1976-08-17 | Medtronic, Inc. | Body-implantable lead |
US5246014A (en) | 1991-11-08 | 1993-09-21 | Medtronic, Inc. | Implantable lead system |
US5397343A (en) | 1993-12-09 | 1995-03-14 | Medtronic, Inc. | Medical electrical lead having counter fixation anchoring system |
US6178355B1 (en) | 1997-04-29 | 2001-01-23 | Medtronic, Inc. | Intracardiac defibrillation leads |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7060030B2 (en) | 2002-01-08 | 2006-06-13 | Cardiac Pacemakers, Inc. | Two-hop telemetry interface for medical device |
EP1618829A1 (en) * | 2003-04-25 | 2006-01-25 | Olympus Corporation | Radio-type in-subject information acquisition system, device for introduction into subject, and outside-subject device |
EP1618829A4 (en) * | 2003-04-25 | 2010-07-07 | Olympus Corp | Radio-type in-subject information acquisition system, device for introduction into subject, and outside-subject device |
US8038601B2 (en) | 2003-04-25 | 2011-10-18 | Olympus Corporation | Wireless in-vivo information acquiring system, body-insertable device, and external device |
JP2007529274A (en) * | 2004-03-15 | 2007-10-25 | カーディアック・ペースメーカーズ・インコーポレーテッド | Secure authentication of data exchange sessions using implantable medical devices |
US7831828B2 (en) | 2004-03-15 | 2010-11-09 | Cardiac Pacemakers, Inc. | System and method for securely authenticating a data exchange session with an implantable medical device |
WO2009105646A1 (en) * | 2008-02-21 | 2009-08-27 | Boston Scientific Neuromodulation Corporation | Temporary neurostimulation lead identification device |
Also Published As
Publication number | Publication date |
---|---|
US20040078067A1 (en) | 2004-04-22 |
JP2004538058A (en) | 2004-12-24 |
DE60223146D1 (en) | 2007-12-06 |
US7239916B2 (en) | 2007-07-03 |
EP1409075B1 (en) | 2007-10-24 |
DE60223146T2 (en) | 2008-07-31 |
US20030018369A1 (en) | 2003-01-23 |
CA2454020A1 (en) | 2003-01-30 |
US20040176822A1 (en) | 2004-09-09 |
JP4299661B2 (en) | 2009-07-22 |
EP1409075A2 (en) | 2004-04-21 |
WO2003008037A3 (en) | 2003-05-22 |
US6675049B2 (en) | 2004-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1409075B1 (en) | Automatic implantable medical lead recognition and configuration | |
US7792588B2 (en) | Radio frequency transponder based implantable medical system | |
US8515559B2 (en) | Communication dipole for implantable medical device | |
US4543955A (en) | System for controlling body implantable action device | |
US8983619B2 (en) | Testing communication during implantation | |
US9610450B2 (en) | Antenna for an implantable medical device | |
US8412352B2 (en) | Communication dipole for implantable medical device | |
US6424867B1 (en) | Secure telemetry system and method for an implantable cardiac stimulation device | |
US8019419B1 (en) | Methods and apparatus for leadless, battery-less, wireless stimulation of tissue | |
US8401662B2 (en) | Performance assessment and adaptation of an acoustic communication link | |
US20140100627A1 (en) | Leadless intra-cardiac medical device with integrated l-c resonant circuit pressure sensor | |
EP2636426B1 (en) | RF-powered communication for implantable device | |
US10874863B2 (en) | Electrode lead, implant, and method for identifying an electrode lead | |
US9067073B2 (en) | Method and apparatus for storing up-to-date information on an implantable medical device | |
WO2008066424A1 (en) | Device and method for initiating communication with a selected implantable medical device by means of a directional antenna | |
US8639350B2 (en) | Telemetry double buffering and oversampling for an implantable medical device | |
US20040215291A1 (en) | Programmer storage of implantable medical device settings |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2454020 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003513639 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002756583 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002756583 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002756583 Country of ref document: EP |